BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026)
BioNTech SE (BNTX) posted Current Deferred Revenue of $101.82 million for Q2 2026, down 88.6% from $891.64 million a year earlier and down 0.8% from the prior quarter.
BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026) Analysis & Trends
At the end of FY2025, BioNTech SE's Current Deferred Revenue came in at $102.44 million, down 47.6% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- In prior years, BioNTech SE's Current Deferred Revenue was $195.55 million in FY2024 (-54.4%), $428.76 million in FY2023 (+768.3%), $49.38 million in FY2022 (+379.6%) and $10.3 million in FY2021 (-87.5%).
- The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2023.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with an average decline of 19.1% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 768.3%; the weakest was Q2 2026, with a decline of 88.6%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $102.67 million (Q1 2026), $102.44 million (Q4 2025) and $256.02 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.90 Bn | 1,139.49 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 643.26 Bn | 561.78 Bn | 17.26 Bn |
| 3 | AbbVie | 501.85 Bn | 474.96 Bn | 12.70 Bn |
| 4 | Merck | 370.72 Bn | 325.10 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.56 Bn | 266.55 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.35 Bn | 242.04 Bn | 12.86 Bn |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.22 Bn | 167.42 Bn | 6.22 Bn |
| 9 | Pfizer | 172.25 Bn | 118.90 Bn | 10.94 Bn |
| 10 | BioNTech SE | 22.03 Bn | -24.45 Bn | 10.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.06 Mn |
| Mar 31, 2026 | 100.50 Mn |
| Dec 31, 2025 | 103.38 Mn |
| Sep 30, 2025 | 256.92 Mn |
| Jun 30, 2025 | 923.77 Mn |
| Mar 31, 2025 | 197.97 Mn |
| Dec 31, 2024 | 190.43 Mn |
| Sep 30, 2024 | 420.99 Mn |
| Jun 30, 2024 | 378.65 Mn |
| Mar 31, 2024 | 409.33 Mn |
| Dec 31, 2023 | 441.07 Mn |
| Sep 30, 2023 | 283.07 Mn |
| Jun 30, 2023 | 328.32 Mn |
| Mar 31, 2023 | 49.73 Mn |
| Dec 31, 2022 | 51.60 Mn |
| Sep 30, 2022 | 52.88 Mn |
| Jun 30, 2022 | 58.40 Mn |
| Mar 31, 2022 | 74.11 Mn |
| Dec 31, 2021 | 10.19 Mn |
| Sep 30, 2021 | 12.18 Mn |
BioNTech SE Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();